Business Description
Oragenics Inc
NAICS : 325412
SIC : 2834
ISIN : US6840233026
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 10.79 | |||||
Equity-to-Asset | 0.64 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 31.1 | |||||
3-Year EPS without NRI Growth Rate | 31.3 | |||||
3-Year FCF Growth Rate | 41.1 | |||||
3-Year Book Growth Rate | -56.8 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.39 | |||||
9-Day RSI | 41.97 | |||||
14-Day RSI | 36.27 | |||||
6-1 Month Momentum % | -65.17 | |||||
12-1 Month Momentum % | -49.81 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.15 | |||||
Quick Ratio | 2.15 | |||||
Cash Ratio | 1.94 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -26.3 | |||||
Shareholder Yield % | 4.76 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -257.08 | |||||
ROA % | -214.2 | |||||
ROIC % | -1383.09 | |||||
ROC (Joel Greenblatt) % | -1743.74 | |||||
ROCE % | -254.64 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.09 | |||||
Price-to-Tangible-Book | 2.09 | |||||
EV-to-EBIT | -0.16 | |||||
EV-to-EBITDA | -0.16 | |||||
EV-to-FCF | -0.44 | |||||
Price-to-Net-Current-Asset-Value | 7.13 | |||||
Price-to-Net-Cash | 1.95 | |||||
Earnings Yield (Greenblatt) % | -625 | |||||
FCF Yield % | -152.11 |